<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>The Oxford Fund — Insights</title><description>Commentary from The Oxford Fund on private equity, medical technology, and the business of bringing new medicine to market.</description><link>https://www.theoxfordfund.com/</link><item><title>The Evolving Landscape of Private Equity in 2023: Navigating Opportunities and Challenges</title><link>https://www.theoxfordfund.com/insights/the-evolving-landscape-of-private-equity-in-2023/</link><guid isPermaLink="true">https://www.theoxfordfund.com/insights/the-evolving-landscape-of-private-equity-in-2023/</guid><description>Economic shifts, tech-driven transformation, ESG imperatives, and a changing regulatory picture — the forces reshaping private equity and how firms are responding.</description><pubDate>Tue, 28 Nov 2023 00:00:00 GMT</pubDate></item></channel></rss>